Jan Haavik, MD, dr. med. is professor of biomedicine and senior consultant in psychiatry at Haukeland University hospital.He received training as medical doctor and specialization in adult psychiatry. He has a doctoral degree in biochemistry and has been investigating molecular mechanisms involved in cancer, metabolic diseases, as well as neurological and psychiatric disorders. He has mainly been working in Norway, interspersed with research stays in Sweden, Scotland, Germany, France, USA and The Netherlands. He is involved in several local, national and international collaborative studies and welcomes new collaborations.
In 2004, Haavik started the interdisciplinary research project "ADHD: from clinical characterization to molecular mechanisms", that has resulted in new insights and been influential for practical diagnostics and treatment of patients with ADHD in Norway. He is currently leading the Neurotargeting Research Group at University of Bergen and the interdisciplinary Center for Neuropsychiatric Disorders, with partners from the university hospital and UiB.
Haavik has received several research awards, including the Helse Vest award in 2016 and has been member of the Norwegian Academy of Sciences since 2018.
- 2019. The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites. Brain Stimulation. 1-8. doi: 10.1016/j.brs.2019.05.018
- 2019. Individual Variability in Reaction Time and Prediction of Clinical Response to Methylphenidate in Adult ADHD: A Prospective Open Label Study Using Conners’ Continuous Performance Test II. Journal of Attention Disorders. doi: 10.1177/1087054719829822
- 2019. Nordic OCD & Related Disorders Consortium: Rationale, design, and methods. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. doi: https://doi.org/10.1002/ajmg.b.32756
- 2019. Patterns of psychiatric comorbidity and genetic correlations provide new insights into differences between attention-deficit/hyperactivity disorder and autism spectrum disorder. Biological Psychiatry. 46 pages. doi: 10.1016/j.biopsych.2019.04.021
- 2019. Effect of disease-associated SLC9A9 mutations on protein–protein interaction networks: implications for molecular mechanisms for ADHD and autism. ADHD Attention Deficit and Hyperactivity Disorders. 11: 91-105. doi: 10.1007/s12402-018-0281-x
- 2018. Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study. PLoS ONE. 13. 12 pages. doi: 10.1371/journal.pone.0204516
- 2018. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nature Genetics. 51: 63-75. doi: 10.1038/s41588-018-0269-7
- 2018. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. European Neuropsychopharmacology. 28: 1059-1088. doi: 10.1016/j.euroneuro.2018.08.001
- 2018. Moderating effect of mode of delivery on the genetics of intelligence: Explorative genome-wide analyses in ALSPAC. Brain and Behavior. 1-12. doi: 10.1002/brb3.1144
- 2018. The quaternary structure of human tyrosine hydroxylase: effects of dystonia‐associated missense variants on oligomeric state and enzyme activity. Journal of Neurochemistry. 148: 291-306. doi: 10.1111/jnc.14624
Jan Haavik completed his medical education at the University of Bergen in 1983. As a student, he started his research career in biochemistry, biophysics and molecular biology. He conducted a tour of Bergen and the municipalities of Agder, graduated from the University of Bergen in 1989, and was employed as a professor, 34, at the present Institute of Biomedicine in 1993. In the period 1986-2014 he had nine shorter and longer research stays at outstanding research institutions in Sweden, Scotland, Germany, France, the United States and the Netherlands. From 2002 he has had a 20% position as a general practitioner in psychiatry, first at Øyane DPS and later at Kronstad DPS, both affiliated with Helse Bergen.